Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors
A novel series of triazoloquinazolinone derivatives were designed, synthesised, and evaluated for their in vitro biological activities against the SHP2 protein. Moreover, some compounds were evaluated against A375 cells. The results revealed that target compounds possessed moderate to excellent inhi...
Enregistré dans:
Auteurs principaux: | Rongshuang Luo, Zhongyuan Wang, Dali Luo, Yumei Qin, Chunshen Zhao, Di Yang, Tian Lu, Zhixu Zhou, Zhuyan Huang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Taylor & Francis Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f6b4e6f2b10c48e0b8e1d41569278350 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
par: Xiaozheng Xu, et autres
Publié: (2021) -
Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles
par: Hu Z, et autres
Publié: (2019) -
Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state
par: Paolo Calligari, et autres
Publié: (2021) -
Biological evaluation of novel 6-Arylbenzimidazo [1,2-c] quinazoline derivatives as inhibitors of LPS-induced TNF- alpha secretion
par: GALARCE,GLORIA D, et autres
Publié: (2008) -
The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
par: Wu N, et autres
Publié: (2018)